<DOC>
	<DOCNO>NCT01220830</DOCNO>
	<brief_summary>The purpose study evaluate efficacy RFQMR therapy remyelination case Multiple sclerosis . The evaluation do base MRI finding , clinical/ neurological examination assessment quality life completion therapy .</brief_summary>
	<brief_title>Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy Multiple Sclerosis</brief_title>
	<detailed_description>Transmembrane Potential ( TMP ) one know cellular signalling pathway regulate synthesis various protein like responsible program cell death ( e.g. , p53 group ) appropriate time live cell . Many illness like cancer degenerative disease link disturbance transmembrane potential protein transcription process . ( Cone CD , 1970 ) The protein responsible production myelin oligodendrocytes Connexin 32 . It establish case Multiple Sclerosis ( MS ) protein synthesize oligodendrocyte thus lead non-repair demyelination process Central Nervous System ( CNS ) ( Scherer SS et al. , 1995 ; Sargiannidou I et al. , 2009 ; Bondurand N et al. , 2001 ) . This cause fibrotic damage plaque formation consequent sign symptoms MS. RFQMR therapy address process stimulation Oligodendrocytes synthesize Connexin 32 thus cause remyelination . RFQMR therapy deliver CYTOTRON® . This device long body , wide bore machine 864 gun , near field antennae parabolic reflector delivery system . The device capable produce wide range dosimetry , involve multiple modulation fix variable proton density dosimetry . Appropriately modulate multi-harmonic Radio Frequency ( RF ) signal low end electromagnetic spectrum use alter cell signal process use TMP pathway , thus able tackle systemic disorder . Generically known Rotational Field Quantum Nuclear Magnetic Resonance ( RFQMR ) , technology make deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beam RF band harmonic range 3KHz 300 MHz near field delivery use specialize antenna presence high instantaneous magnetic field .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Male female patient clinically definite MS accord Polman Age 18 60 yr . EDSS 0 7 . Relapsefree &gt; 30 day prior inclusion . Stable immunomodulatory immunosuppressive . therapy treatment &gt; 3 month prior inclusion . In case treatment antidepressant : stable therapy &gt; 3 month prior inclusion . Highly effective method birth control females . Pregnancy Cardiac pacemaker , biostimulators , neurostimulators , cochlear implant , hear aid . MRI incompatible implant like intramedullary nail , intracranial aneurysm clip , intraorbital metal fragment , stent , implanted medication pump etc near target area . Critically ill patient need life support system . Mentally challenge patient give informed consent . Severely ill patient lie supine position 1 hour . H/o brain injury and/ malignant disorder Personal family history epilepsy / brain tumor . Relapse MS &lt; 30 day prior inclusion Change immunomodulatory therapy &lt; 30 day prior inclusion Bipolar disorder History stroke brain lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>RFQMR</keyword>
	<keyword>Cytotron</keyword>
	<keyword>EDSS</keyword>
	<keyword>QOL assessment FAMS</keyword>
</DOC>